Medical Equipment Q2 2016: Quarterly Deals Analysis worth USD562.8m in Q2 2016 : M&A and Investment Trends

Deals Decreased in the Medical Equipment Industry in Q2 2016
GlobalData’s “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q2 2016” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financing in the medical equipment market. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in Q2 2016. The report discloses detailed comparative data on the number of deals and their value in the past five quarters, categorized into deal types, segments, and geographies. The report provides information on the top private equity, venture capital and advisory firms in the medical equipment industry.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database and primary and secondary research. 

M&As Decreased In Q2 2016
Mergers and acquisitions (M&As), including asset transactions, recorded a decrease in the number of deals and an increase in deal values in Q2 2016 with 90 deals worth USD30.2 billion, as compared to 137 deals worth USD21.5 billion in Q2 2015. On quarter-on-quarter basis, the number of deals decreased and deal values increased in Q2 2016, when compared with 122 deals worth USD21.2 billion in Q1 2016.

Number Of IPOs Decreased In Q2 2016
Global equity offerings, including initial public offerings (IPO), secondary offerings, and private investment in public equities (PIPEs), recorded a marginal increase in the number of deals and a decrease in deal values with 126 deals worth USD3.2 billion in Q2 2016, compared to 124 deals worth USD4.2 billion in Q2 2015. On a quarter-on-quarter basis, the number of deals and deal values increased in Q2 2016, compared to 77 deals worth USD1.3 billion in Q1 2016.
The IPO market recorded a decrease in the number of deals and deal values with seven deals worth USD223.9m in Q2 2016, compared to 23 deals worth USD2.4 billion in Q2 2015. On a quarter-on-quarter basis, the number of IPOs and their values increased in Q2 2016, compared to two deals worth USD52.2m in Q1 2016. Besides, 42 secondary offerings worth USD2.3 billion and 77 deals worth USD602.9m were reported in Q2 2016.

Receive copy of sample report at : https://marketreportscenter.com/request-sample/387653

Venture Capital Investments Decreased In Q2 2016
The venture capital (VC) segment reported 165 deals worth USD1.6 billion in Q2 2016, as compared to 197 deals worth USD1.9 billion in Q2 2015. On a quarter-on-quarter basis, the number of VC deals and their values decreased in Q2 2016, compared to 188 deals worth USD2.2 billion in Q1 2016.
Khosla Ventures, LLC and New Enterprise Associates, Inc. topped the list of venture financing firms by participating in eight deals each worth USD215.5m and USD160.5m, respectively, between Q2 2015 to Q2 2016.

Deal Values In North America Recorded A Decrease In Q2 2016
North America recorded a decrease in the number of deals and deal values in Q2 2016. The region registered 413 deals worth USD39.7 billion in Q2 2016, compared to 442 deals worth USD46 billion in Q2 2015. On a quarter-on-quarter basis, the number of deals decreased and deal values increased in Q2 2016, when compared to 422 deals worth USD21.3 billion in Q1 2016.
Europe recorded a decrease in the number of deals and an increase in deal values in Q2 2016 with 149 deals worth USD8.6 billion, as compared to 172 deals worth USD6.2 billion in Q2 2015. On a quarter-on-quarter basis, the number of deals and deal values increased in Q2 2016, when compared to 145 deals worth USD2.4 billion in Q1 2016.
Asia Pacific recorded a decrease in the number of deals and deal values in Q2 2016. The region reported 85 deals worth USD562.8m in Q2 2016, as compared to 90 deals worth USD5.2 billion in Q2 2015. On a quarter-on-quarter basis, the number of deals and deal values decreased in Q2 2016, when compared to 86 deals worth USD6.8 billion in Q1 2016.
Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q2 2016

Browse full report with TOC at : https://marketreportscenter.com/reports/387653/medical-equipment-quarterly-deals-analysis-ma-and-investment-trends-q2-2016

Summary

GlobalData’s “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q2 2016” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in Q2 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the medical equipment industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.

Scope

- Analyze market trends for the medical equipment/medical devices market in the global arena
- Review of deal trends in anesthesia and respiratory devices, cardiovascular devices, dental devices, diabetes care devices, diagnostic imaging, drug delivery devices, endoscopy devices, ENT devices, healthcare IT, hospital supplies, in vitro diagnostics, nephrology and urology devices, neurology devices, opthalmic devices, patient monitoring, surgical equipment, and wound care management segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the medical equipment market
- Summary of medical equipment deals globally in the last five quarters
- Information on the top deals that took place in the medical equipment market
- Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of company divesting and acquiring assets and ways to raise capital in the market.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the medical equipment industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Receive Discount at : https://marketreportscenter.com/request-discount/387653

Media contacts:
Sam Collins
Market Reports Center
Call : 1-646-883-3044 (US)
Email : [email protected]
visit our website : https://marketreportscenter.com